choroideremia

The 2022 ARVO conference is taking place in Denver, CO. I am excited to be there networking and learning from the scientists in the field. Here are a few of the Choroideremia related posters and talks that I will be checking out: Sunday Cone inner-segment area and circularity in chorioderemia assessed with split-detection adaptive optics scanning light ophthalmoscopy - Peiluo Xu CHM cones are bigger and more circular. Visualization of the Photoreceptor / RPE / Choriocapillaris Complex in Choroideremia Using Adaptive Optics Enhanced Indocyanine Green Imaging - Nancy Aguilera The RPE was the most disrupted layer....

Disclaimer: None of this should be taken as medical advice. Consult with your doctor. A question was posted in the Choroideremia (CHM) Facebook group about supplements: Hello to all my fellow group mates. Just wanted some input as to what vitamins or supplements you are taking to help with CHM. I have been taking the Bausch and Lomb preservision and would like to know if there is something better or something additional you would recommend....

Washington, DC - Nov. 6, 2019 The American Society of Gene and Cell Therapy held a 3 day summit to discuss policy and other issues around gene editing and gene therapy. Day 1 addressed regulatory issues in gene therapy development Day 2 dealt with payment policies around gene therapy Day 3 (the day I attended) was focused on the ethical, societal, and policy issues around germline gene editing Links to some of the presentations can be found on ASGCT’s website....

Panorama view from Whistler Mountain. These notes from Thursday May 2, the last day of ARVO 2019. The conference had thinned out a bit as some people had to leave, but there were still some presentations of interest. You can read a summary or my notes from the other days here: Friday, Sunday, Monday, Tuesday, and Wednesday. Papers Subfoveal gene augmentation therapy for choroideremia: One-year results from a Phase I/II trial of AAV2-hCHM - Rachel M....

“Digital Orca” sculpture outside of the Vancouver Convention Center. These notes from May 1 are the continuation of a few articles about my time at ARVO. You can read a summary or my notes from the other days here: Friday, Sunday, Monday, Tuesday. Papers AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: 2 year Results of an Ongoing Phase I/II Gene Therapy Trial - Thomas Aleman Aleman presented more follow-up data from this phase I/II clinical trial that was performed on 10 CHM patients....

ARVO 2019 took place at the Vancouver Convention Center from April 28 to May 2 and featured novel work, continued efforts, and updates on clinical trials. On the Friday before ARVO the Foundation Fighting Blindness and the Casey Eye Institute hosted a summit featuring gene therapy, stem cell therapies, and non-viral therapies. Randy Wheelock had been organizing a special interest group on Sunday to discuss combination therapies before his passing....

ARVO poster area B. Roughly 1,000 new posters are displayed every day of ARVO. See my notes from Sunday and Monday. Patient Engagement in Ophthalmology Research This special interest group discussed current methods of patient involvement in research and explored new ways this could be improved. A special emphasis was put on international policies, specifically in Europe and Canada. BC SUPPORT is one of the branches of the SPOR initiative across Canada meant to include patients and caregivers in research design....

The Vancouver Convention Center’s East Building These are my notes from the second day at ARVO 2019. Check out Sunday’s notes if you missed them. Changing What it Means to be Blind: We’re All in This Together This session took place late in the evening and was put together by Kristin Smedley from the Curing Retinal Blindness Foundation. Smedley began the session by playing a TEDx talk she gave in 2017 at Lincoln Square....